Aurobindo Pharma Limited
Water Mark Building Plot No. 11
Survey no.9 Kondapur Hitech City
- With Kompass :
Global presence in more than 60 countries
Detailed and up to date company information
Comprehensive and filtered company directory
Associated Companies: APL Healthcare Limited
APL Research Centre Limited
Auronext Pharma Private Limited
Novagen South Africa (JV)
Aurobindo Ilac Sanayi Ve Ticaret Limited STI
APL Swift Services (Malta) Limited
Agile Pharma (Malta) Limited
Agile Malta Holdings
Aurohealthcare (Nigeria) Limited
Aurolife Pharma Limited Liability Company
Aurosal Pharmaceuticals LLC (JV)APL Holdings (Jersey) Limited
APL IP company Limited
Laboratorios Aurobindo S.L.
ALL Pharma (Shangai) Trading Company Limited.
Helix healthcare B.V.
Type of company
+91 40 23741080, 23746833
- Standard Chartered Bank, Indian Bank, IDBI Bank Limited, Citibank N.A., State Bank of Hyderabad, State Bank of India, ICICI Bank, HDFC Bank Ltd., Andhra Bank, Canara Bank Standard Chartered Bank,Indian Bank,IDBI Bank Limited,Citibank N.A.,State Bank of Hyderabad,State Bank of India,ICICI Bank,HDFC Bank Ltd.,Andhra Bank,Canara Bank
2 April, 2014
Hyderabad: Aurobindo Pharma Ltd has completed the acquisition of certain commercial operations in Western Europe from Actavis Plc. In January this year, the Hyderabad-based Aurobindo Pharma had signed an agreement with Actavis to acquire its personnel, commercial infrastructure, products, marketing authorisations and dossier licence rights in seven European countries for €30 million.
Both companies had also inked a long-term commercial and supply arrangement.
“The acquisition will make Aurobindo one of the leading Indian pharmaceutical companies in Europe with a top 10 position in several key markets,’’ Muralidharan, Senior Vice-President of European operations for Aurobindo, said here on Tuesday.
Aurobindo would work to combine the strength of both enterprises in these markets and to identify and maximise all opportunities.
“We will continue to collaborate with Actavis to ensure business continuity and a smooth transition. In parallel, we will work closely with the acquired management teams to achieve a rapid and successful integration,’’ he added. Aurobindo’s scrip gained 4.67 per cent on BSE on Tuesday to end at Rs. 534.70.
Disclaimer: Orignal source from IBEF http://ibef.org/news/aurobindo-pharma-acquires-actavis-operations-in-7-european-countries
More than 5000 Employees
Mr. P. S.
- Service provider
- Pharmaceutical preparations for the central and autonomic nervous system and anaesthetics
- Pharmaceutical preparations for the cardiovascular system
- Pharmaceutical preparations for metabolism, nutrition, alimentary systems
You might also like
Aurobindo Pharma Limited
All the lines are busy at the moment, please try again in a moment.